Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life ...

Retrieved on: 2024-12-02 13:11:46

Tags for this article:

Click the tags to see associated articles and topics

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life .... View article details on hiswai:

Excerpt

... monoclonal antibodies. "TL1A inhibition has demonstrated compelling efficacy in ulcerative colitis and Crohn's disease patients and has been shown ...

Article found on: www.prnewswire.com

View Original Article